3 hours Cytokinetics (NASDAQ:CYTK) PT Raised to $120.00 at HC Wainwright MarketBeat
HC Wainwright raised their price target on Cytokinetics from $90.00 to $120.00 and gave the company a “buy” rating in a research note on Wednesday.
HC Wainwright raised their price target on Cytokinetics from $90.00 to $120.00 and gave the company a “buy” rating in a research note on Wednesday.